All News #Library
Biotech
Beyondspring Presents Plinabulin And ADC Combo Poster At AACR
30 Mar 2026 //
GLOBENEWSWIRE
Beyondspring Reports 2025 Year-End Financial Results
25 Mar 2026 //
GLOBENEWSWIRE
Beyondspring To Attend 12Th Immuno-Oncology 360° Conference
09 Feb 2026 //
GLOBENEWSWIRE
Beyondspring Presents Plinabulin + Docetaxel Data At ESMO Asia
12 Dec 2025 //
GLOBENEWSWIRE
Beyondspring Reveals Ph3 of Plinabulin+Docetaxel Survival Benefit
11 Dec 2025 //
GLOBENEWSWIRE
BeyondSpring`s Plinabulin Drives Dendritic Cell Maturation
07 Jul 2025 //
GLOBENEWSWIRE
BeyondSpring Presents Data on Pembrolizumab Combo in NSCLC
03 Jun 2025 //
GLOBENEWSWIRE
BeyondSpring Presents Phase 2 Efficacy of Pembrolizumab Combo
11 Nov 2024 //
GLOBENEWSWIRE
BeyondSpring Announces 1st Patient Dosed Pembrolizumab,Plinabulin Plus Etoposide
25 Mar 2024 //
GLOBENEWSWIRE
BeyondSpring Enrolls First Patient in Ph2 Study Plinabulin, Keytruda & Docetaxel
01 Mar 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support